查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916713

精准医疗解决方案市场预测至2032年：按产品、交付方式、技术、应用、最终用户和地区分類的全球分析

Precision Medicine Solutions Market Forecasts to 2032 - Global Analysis By Product (Diagnostics, Software, Therapeutics and Services), Delivery Mode, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球精准医疗解决方案市场预计将在 2025 年达到 777 亿美元，并在 2032 年达到 1,665 亿美元，在预测期内以 11.5% 的复合年增长率成长。

精准医疗解决方案是一种医疗保健方法，它根据个人的基因谱、生活方式和环境，客製化预防、诊断和治疗方案。透过利用基因组学、蛋白质组学和生物资讯学等先进工具，这些解决方案能够提供标靶治疗，最大限度地提高疗效并减少副作用。透过分析患者的特定数据，临床医生可以确定最佳治疗方法、预测疾病风险并提供预防性护理。这种个人化方法正推动医疗保健从「一刀切」的模式转向精准的、数据驱动的策略，从而改善治疗效果并提高整体医疗效率。

整合人工智慧和巨量资料分析

人工智慧 (AI) 与巨量资料分析的整合是精准医疗解决方案市场的关键驱动力。这些技术能够收集、处理和解读海量的患者资料集，包括基因组学、蛋白质组学和临床病史。透过发现模式和预测性见解，人工智慧可以增强决策能力，推动个人化治疗方案的製定，并加速药物研发。这种智慧化的、数据驱动的方法能够改善临床疗效，减少试验误治疗，并提升精准医疗在全球的整体效率和普及程度。

精准医疗解决方案的高成本

先进诊断工具、基因检测和个人化治疗的高昂成本是限制市场成长的一大因素。许多医疗系统和患者面临经济障碍，限制了他们获得这些服务的机会。此外，对专用基础设施、训练有素的人员以及持续资料管理的需求也进一步推高了成本。这种经济挑战减缓了技术的普及，限制了市场潜力，尤其是在发展中地区，对于寻求精准医疗解决方案的医疗服务提供者和患者而言，价格仍然是他们最为关注的问题。

向预防性和个人化医疗保健的转变

全球对预防性和个人化医疗的日益重视为市场带来了巨大的机会。患者和医疗服务提供者越来越关注早期检测、风险预测和个人化治疗方案。这种转变正在推动基因组学、生物资讯学和患者特定数据分析领域的投资。透过实现预防性介入和标靶治疗，精准医疗能够有效应对慢性疾病并改善患者预后。对个人化医疗解决方案日益增长的需求，将为未来几年市场的持续成长和创新奠定基础。

监理和合规挑战

监管和合规方面的挑战对市场构成重大威胁。关于基因检测、病患资料隐私、临床试验和药物核准的严格法规可能会延迟产品上市和市场准入。各国标准不一也增加了全球部署的复杂性。遵守 GDPR 和 HIPAA 等资料保护法律需要健全的系统和流程。这些监管障碍会限制创新、增加营运成本并造成不确定性，可能阻碍精准医疗解决方案在全球的普及和推广。

新冠疫情的影响：

新冠疫情对市场产生了复杂的影响。一方面，它加速了数位医疗、远端医疗和数据驱动诊断的普及，凸显了个人化医疗的价值。另一方面，研究中断、供应链中断以及资源转移到对抗疫情，导致部分临床试验延期，精准医疗计划也随之延后。整体而言，这场危机凸显了个人化医疗的重要性，虽然为市场营运和投资带来了暂时的挑战，但也为长期成长创造了机会。

预计在预测期内，生物资讯学将占据最大的市场规模。

在预测期内，生物资讯学领域预计将占据最大的市场份额，这主要归功于其在数据分析和解读方面发挥的关键作用。生物资讯学能够整合基因体学、蛋白质体学和临床数据，进而助力精准诊断和个人化治疗方案的发展。其在药物研发、预测建模和病患分层等方面的应用已成为医疗保健机构不可或缺的一部分。医院、研究机构和製药公司对生物资讯学的日益普及正在推动其市场主导地位，使其成为全球精准医疗解决方案的基础。

预计在预测期内，心臟病学领域将实现最高的复合年增长率。

由于基因检测、生物标记分析和患者特异性风险评估技术的进步，使得个人化心血管护理成为可能，预计在预测期内，心臟病学领域将实现最高的成长率。心臟病患病率的不断上升，以及早期检测和早期疗育策略的进步，正在推动心臟病学领域对精准医疗解决方案的需求。预测模型、穿戴式装置和标靶治疗的创新进一步促进了这些技术的快速普及。这些因素共同作用，使心臟病学成为精准医疗领域中一个高成长的细分市场。

占比最大的地区：

由于医疗保健投资不断增长、慢性病患病率上升以及先进诊断技术的应用日益普及，亚太地区预计将在预测期内占据最大的市场份额。政府推动基因组研究、改善医疗基础设施以及提高患者意识的倡议，都为市场扩张提供了支持。该地区庞大的人口规模和对个人化治疗方案的需求，也促进了市场的持续成长，使亚太地区成为全球精准医疗领域的主导。

年复合成长率最高的地区：

预计北美在预测期内将实现最高的复合年增长率，这主要得益于其区域优势，例如先进的医疗基础设施、充足的研究经费以及基因组学和生物资讯技术的早期应用。主要市场参与者的强大实力、有利的法规结构以及对个人化治疗日益增长的需求，都在推动市场快速成长。此外，慢性病盛行率的上升以及对精准诊断的重视，正在加速创新医疗解决方案的普及，使北美成为成长最快的区域市场。

免费客製化服务资讯：

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章 全球精准医疗解决方案市场（依产品划分）

  • 诊断
  • 软体
  • 治疗药物
  • 服务

第六章 全球精准医疗解决方案市场（以交付方式划分）

  • 基于云端的解决方案
  • 本地部署解决方案
  • 混合解决方案

7. 全球精准医疗解决方案市场（依技术划分）

  • 基因组学
  • 巨量资料分析
  • 人工智慧/机器学习
  • 生物资讯学
  • 其他技术

第八章 全球精准医疗解决方案市场（按应用领域划分）

  • 肿瘤学
  • 感染疾病
  • 心臟病学
  • 罕见疾病
  • 神经病学
  • 呼吸系统
  • 其他用途

9. 全球精准医疗解决方案市场（依最终用户划分）

  • 医院和诊所
  • 医疗保健提供者
  • 诊断中心/实验室
  • 研究机构和学术中心
  • 製药和生物技术公司
  • 其他最终用户

第十章 全球精准医疗解决方案市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：企业概况

  • Illumina
  • GE Healthcare
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Pfizer
  • Abbott Laboratories
  • Novartis
  • Foundation Medicine
  • AstraZeneca
  • Tempus AI
  • Merck &Co.
  • Guardant Health
  • QIAGEN
  • Bristol-Myers Squibb
  • Roche
Product Code: SMRC33286

According to Stratistics MRC, the Global Precision Medicine Solutions Market is accounted for $77.7 billion in 2025 and is expected to reach $166.5 billion by 2032 growing at a CAGR of 11.5% during the forecast period. Precision Medicine Solutions are healthcare approaches that customize prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. Using advanced tools like genomics, proteomics, and bioinformatics, these solutions enable targeted therapies that maximize effectiveness while reducing side effects. By analyzing patient-specific data, clinicians can identify the most suitable interventions, anticipate disease risks, and deliver proactive care. This personalized approach shifts medicine from a one-size-fits-all model to precise, data-driven strategies that improve outcomes and overall healthcare efficiency.

Market Dynamics:

Driver:

Integration of AI & Big Data Analytics

The integration of artificial intelligence (AI) and big data analytics is a key driver of the Precision Medicine Solutions market. These technologies enable the collection, processing, and interpretation of vast patient data sets, including genomics, proteomics, and clinical histories. By uncovering patterns and predictive insights, AI enhances decision-making, facilitates personalized treatment plans, and accelerates drug discovery. This intelligent, data-driven approach improves clinical outcomes, reduces trial-and-error treatments, and strengthens the overall efficiency and adoption of precision medicine globally.

Restraint:

High Cost of Precision Medicine Solutions

A significant restraint on the growth of the market is the high cost associated with advanced diagnostic tools, genetic testing, and personalized therapies. Many healthcare systems and patients face financial barriers, limiting accessibility. The requirement for specialized infrastructure, trained personnel, and continuous data management further escalates costs. This financial challenge slows widespread adoption, particularly in developing regions, and constrains the market's potential, as affordability remains a critical concern for both providers and patients seeking precision healthcare solutions.

Opportunity:

Shift toward Preventive & Personalized Healthcare

The growing global emphasis on preventive and personalized healthcare presents a substantial opportunity for the market. Patients and providers are increasingly focused on early detection, risk prediction, and individualized treatment plans. This shift encourages investment in genomics, bioinformatics, and patient-specific data analysis. By enabling proactive interventions and targeted therapies, precision medicine addresses chronic diseases and improves patient outcomes. The rising demand for tailored healthcare solutions positions the market for sustained growth and innovation over the coming years.

Threat:

Regulatory & Compliance Challenges

Regulatory and compliance challenges pose a significant threat to the market. Strict regulations surrounding genetic testing, patient data privacy, clinical trials, and drug approvals can delay product launches and market entry. Varying standards across countries increase complexity for global implementation. Compliance with data protection laws, such as GDPR and HIPAA, requires robust systems and processes. These regulatory hurdles may limit innovation, increase operational costs, and create uncertainties, restraining the speed of adoption and expansion of precision medicine solutions worldwide.

Covid-19 Impact:

The COVID-19 pandemic has had a mixed impact on the market. On one hand, it accelerated the adoption of digital healthcare, telemedicine, and data-driven diagnostics, highlighting the value of personalized approaches. On the other hand, research disruptions, supply chain interruptions, and resource diversion to pandemic response slowed certain clinical trials and delayed precision medicine projects. Overall, the crisis underscored the importance of personalized healthcare, creating long-term growth prospects while temporarily challenging market operations and investments.

The bioinformatics segment is expected to be the largest during the forecast period

The bioinformatics segment is expected to account for the largest market share during the forecast period, due to its critical role in data analysis and interpretation. Bioinformatics enables the integration of genomic, proteomic, and clinical data to support precision diagnosis and personalized treatment planning. Its applications in drug discovery, predictive modeling, and patient stratification make it indispensable for healthcare providers. Increasing adoption by hospitals, research institutions, and pharmaceutical companies drives market dominance, positioning bioinformatics as the cornerstone of precision medicine solutions globally.

The cardiology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cardiology segment is predicted to witness the highest growth rate, due to advancements in genetic testing, biomarker analysis, and patient-specific risk assessments are enabling personalized cardiovascular care. Rising prevalence of heart disease, coupled with early detection and intervention strategies, drives demand for precision medicine solutions in cardiology. Innovations in predictive modeling, wearable devices, and targeted therapies further support rapid adoption. These factors collectively position cardiology as a high-growth segment within the precision medicine landscape.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to increasing healthcare investments, rising prevalence of chronic diseases, and expanding adoption of advanced diagnostics. Government initiatives to promote genomic research, coupled with improving healthcare infrastructure and growing patient awareness, support market expansion. The region's large population base and demand for personalized treatment solutions contribute to sustained growth, making Asia Pacific a dominant player in the global precision medicine landscape.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region benefits from advanced healthcare infrastructure, extensive research funding, and early adoption of genomics and bioinformatics technologies. Strong presence of key market players, supportive regulatory frameworks, and growing demand for personalized therapies drive rapid market growth. Additionally, increasing chronic disease prevalence and a focus on precision diagnostics accelerate the adoption of innovative healthcare solutions, positioning North America as the fastest-growing regional market.

Key players in the market

Some of the key players in Precision Medicine Solutions Market include Illumina, GE Healthcare, Thermo Fisher Scientific, Siemens Healthineers, Pfizer, Abbott Laboratories, Novartis, Foundation Medicine, AstraZeneca, Tempus AI, Merck & Co., Guardant Health, QIAGEN, Bristol-Myers Squibb, and Roche.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Products Covered:

  • Diagnostics
  • Software
  • Therapeutics
  • Services

Delivery Modes Covered:

  • Cloud-based Solutions
  • On-Premise Solutions
  • Hybrid Solutions

Technologies Covered:

  • Genomics
  • Big Data Analytics
  • Artificial Intelligence / Machine Learning
  • Bioinformatics
  • Other Technologies

Applications Covered:

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Rare Diseases
  • Neurology
  • Respiratory
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Healthcare Providers
  • Diagnostic Centers/Laboratories
  • Research Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Precision Medicine Solutions Market, By Product

  • 5.1 Introduction
  • 5.2 Diagnostics
  • 5.3 Software
  • 5.4 Therapeutics
  • 5.5 Services

6 Global Precision Medicine Solutions Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 Cloud-based Solutions
  • 6.3 On-Premise Solutions
  • 6.4 Hybrid Solutions

7 Global Precision Medicine Solutions Market, By Technology

  • 7.1 Introduction
  • 7.2 Genomics
  • 7.3 Big Data Analytics
  • 7.4 Artificial Intelligence / Machine Learning
  • 7.5 Bioinformatics
  • 7.6 Other Technologies

8 Global Precision Medicine Solutions Market, By Application

  • 8.1 Introduction
  • 8.2 Oncology
  • 8.3 Infectious Diseases
  • 8.4 Cardiology
  • 8.5 Rare Diseases
  • 8.6 Neurology
  • 8.7 Respiratory
  • 8.8 Other Applications

9 Global Precision Medicine Solutions Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Healthcare Providers
  • 9.4 Diagnostic Centers/Laboratories
  • 9.5 Research Institutes & Academic Centers
  • 9.6 Pharmaceutical & Biotechnology Companies
  • 9.7 Other End Users

10 Global Precision Medicine Solutions Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Illumina
  • 12.2 GE Healthcare
  • 12.3 Thermo Fisher Scientific
  • 12.4 Siemens Healthineers
  • 12.5 Pfizer
  • 12.6 Abbott Laboratories
  • 12.7 Novartis
  • 12.8 Foundation Medicine
  • 12.9 AstraZeneca
  • 12.10 Tempus AI
  • 12.11 Merck & Co.
  • 12.12 Guardant Health
  • 12.13 QIAGEN
  • 12.14 Bristol-Myers Squibb
  • 12.15 Roche

List of Tables

  • Table 1 Global Precision Medicine Solutions Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Precision Medicine Solutions Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Precision Medicine Solutions Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 4 Global Precision Medicine Solutions Market Outlook, By Software (2024-2032) ($MN)
  • Table 5 Global Precision Medicine Solutions Market Outlook, By Therapeutics (2024-2032) ($MN)
  • Table 6 Global Precision Medicine Solutions Market Outlook, By Services (2024-2032) ($MN)
  • Table 7 Global Precision Medicine Solutions Market Outlook, By Delivery Mode (2024-2032) ($MN)
  • Table 8 Global Precision Medicine Solutions Market Outlook, By Cloud-based Solutions (2024-2032) ($MN)
  • Table 9 Global Precision Medicine Solutions Market Outlook, By On-Premise Solutions (2024-2032) ($MN)
  • Table 10 Global Precision Medicine Solutions Market Outlook, By Hybrid Solutions (2024-2032) ($MN)
  • Table 11 Global Precision Medicine Solutions Market Outlook, By Technology (2024-2032) ($MN)
  • Table 12 Global Precision Medicine Solutions Market Outlook, By Genomics (2024-2032) ($MN)
  • Table 13 Global Precision Medicine Solutions Market Outlook, By Big Data Analytics (2024-2032) ($MN)
  • Table 14 Global Precision Medicine Solutions Market Outlook, By Artificial Intelligence / Machine Learning (2024-2032) ($MN)
  • Table 15 Global Precision Medicine Solutions Market Outlook, By Bioinformatics (2024-2032) ($MN)
  • Table 16 Global Precision Medicine Solutions Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 17 Global Precision Medicine Solutions Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Precision Medicine Solutions Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 19 Global Precision Medicine Solutions Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 20 Global Precision Medicine Solutions Market Outlook, By Cardiology (2024-2032) ($MN)
  • Table 21 Global Precision Medicine Solutions Market Outlook, By Rare Diseases (2024-2032) ($MN)
  • Table 22 Global Precision Medicine Solutions Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 23 Global Precision Medicine Solutions Market Outlook, By Respiratory (2024-2032) ($MN)
  • Table 24 Global Precision Medicine Solutions Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 25 Global Precision Medicine Solutions Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Precision Medicine Solutions Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 27 Global Precision Medicine Solutions Market Outlook, By Healthcare Providers (2024-2032) ($MN)
  • Table 28 Global Precision Medicine Solutions Market Outlook, By Diagnostic Centers/Laboratories (2024-2032) ($MN)
  • Table 29 Global Precision Medicine Solutions Market Outlook, By Research Institutes & Academic Centers (2024-2032) ($MN)
  • Table 30 Global Precision Medicine Solutions Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 31 Global Precision Medicine Solutions Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.